Add-on therapy with topiramate in progressive myoclonic epilepsy

Epilepsy and Behavior

Volumn 6, Issue 2, 2005, Pages 260-263

  Aykutlu, Ebru ^a   Baykan, Betül ^a   Gürses, Candan ^a   Bebek, Nerses ^a   Büyükbabani, Nesimi ^a   Gökyiǧit, Ayşen ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Myoclonus; Progressive myoclonus epilepsy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PIRACETAM; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ARTICLE; ATAXIA; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; LETHARGY; MALE; MENSTRUAL IRREGULARITY; MYOCLONUS EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY POLYCYSTIC DISEASE; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINE INCONTINENCE; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTICONVULSANTS; DISABILITY EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MYOCLONIC EPILEPSIES, PROGRESSIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 13844281102     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.11.014     Document Type: Article

References (14)

1. P. Genton A. Malafosse B. Moulard et al. Progressive myoclonus epilepsies. In: J. Roger M. Bureau C. Dravet P. Genton C.A. Tassinari P. Wolf editors. Epileptic syndromes in infancy, childhood and adolescence 3rd ed 2002 John Libbey London 407-430
2. R. Michelucci J.M. Serratosa P. Genton C.A. Tassinari Seizures, myoclonus and cerebellar dysfunction in progressive myoclonus epilepsies. In: R. Guerrini J. Aicardi F. Andermann M. Hallett editors. Epilepsy and movement disorders 2nd ed 2002 Cambridge Univ. Press London 227-249
3. S.F. Berkovic J. Cochius E. Andermann F. Andermann Progressive myoclonus epilepsies: Clinical and genetic aspects Epilepsia 34 Suppl. 3 1993 S19-30
4. M. Koskiniemi B. van Vleymen L. Hakamies S. Lamusuo J. Taas Piracetam relieves symptoms in progressive myoclonus epilepsy: A multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo J Neurol Neurosurg Psychiatry 64 1998 334-348
5. M. Fedi D. Reutens F. Dubeau et al. Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy Arch Neurol 58 2001 781-788
6. C. Crest S. Dupont E. Leguern C. Adam M. Baulac Levetiracetam in progressive myoclonic epilepsy: An exploratory study in 9 patients Neurology 62 2004 640-643
7. A. Magaudda P. Gelisse P. Genton Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: Clinical observations Epilepsia 45 2004 678-682
8. T.R. Henry I.E. Leppik R.J. Gumnit M. Jacobs Progressive myoclonus epilepsy treated with zonisamide Neurology 38 1988 928-931
9. M. Kyllerman E. Ben-Menachem Zonisamide for progressive myoclonus epilepsy: Long-term observations in seven patients Epilepsy Res 29 1998 109-114
10. Topiramate YTC/YTCE Study Group. Nonfocal generalized tonic-clonic seizures: Response during long-term topiramate treatment. Epilepsia 2000;41(Suppl. 1): S77-81
11. R.W. Hurd B.J. Wilder W.R. Helveston et al. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine Neurology 47 1996 1264-1268
12. B. Bourgeois Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed? Neurology 55 2000 11-17
13. S.I. Johannessen Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs Epilepsia 38 1997 18-23
14. S.J. Wallace Newer antiepileptic drugs: Advantages and disadvantages Brain Dev 23 2001 277-283